BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pakraftar S, Atencio D, English J, Corcos A, Altschuler EM, Stahlfeld K. Dabigatran etixilate and traumatic brain injury: Evolving anticoagulants require evolving care plans. World J Clin Cases 2014; 2(8): 362-366 [PMID: 25133148 DOI: 10.12998/wjcc.v2.i8.362]
URL: https://www.wjgnet.com/2307-8960/full/v2/i8/362.htm
Number Citing Articles
1
Variation in Blood Transfusion and Coagulation Management in Traumatic Brain Injury at the Intensive Care Unit: A Survey in 66 Neurotrauma Centers Participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury StudyJournal of Neurotrauma 2018; 35(2): 323 doi: 10.1089/neu.2017.5194
2
Sariya Udayachalerm, Sasivimol Rattanasiri, Teeranan Angkananard, John Attia, Nakarin Sansanayudh, Ammarin Thakkinstian. The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-AnalysisClinical and Applied Thrombosis/Hemostasis 2018; 24(9_suppl): 117S doi: 10.1177/1076029618796339
3
Tomasz Tykocki, Krystyna Guzek. Anticoagulation Therapy in Traumatic Brain InjuryWorld Neurosurgery 2016; 89: 497 doi: 10.1016/j.wneu.2016.01.063
4
Anthony Pozzessere, Jonathan Grotts, Stephen Kaminski. Dabigatran Use Does Not Increase Intracranial Hemorrhage in Traumatic Geriatric Falls When Compared with WarfarinThe American Surgeon 2015; 81(10): 1039 doi: 10.1177/000313481508101025
5
Simon T. Schäfer, Anne-Christine Otto, Alice-Christin Acevedo, Klaus Görlinger, Steffen Massberg, Tobias Kammerer, Philipp Groene. Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithmsThrombosis Journal 2021; 19(1) doi: 10.1186/s12959-021-00313-7
6
Drew A. Spencer, Paul D. Ackerman, Omer Iqbal, Christopher M. Loftus. Anticoagulation and Hemostasis in Neurosurgery2016; : 381 doi: 10.1007/978-3-319-27327-3_29
7
Adrian A. Maung, Bishwajit Bhattacharya, Kevin M. Schuster, Kimberly A. Davis. Trauma patients on new oral anticoagulation agents have lower mortality than those on warfarinJournal of Trauma and Acute Care Surgery 2016; 81(4): 652 doi: 10.1097/TA.0000000000001189
8
Muhammad Zeeshan, Faisal Jehan, Terence O’Keeffe, Muhammad Khan, El Rasheid Zakaria, Mohammad Hamidi, Lynn Gries, Narong Kulvatunyou, Bellal Joseph. The novel oral anticoagulants (NOACs) have worse outcomes compared with warfarin in patients with intracranial hemorrhage after TBIJournal of Trauma and Acute Care Surgery 2018; 85(5): 915 doi: 10.1097/TA.0000000000001995
9
George P. Liao, John B. Holcomb. Neurotrauma Management for the Severely Injured Polytrauma Patient2017; : 51 doi: 10.1007/978-3-319-40208-6_7
10
Victoria L Watson, Nundia Louis, Brittany V Seminara, J Paul Muizelaar, Anthony Alberico. Proposal for the Rapid Reversal of Coagulopathy in Patients with Nonoperative Head Injuries on Anticoagulants and/or Antiplatelet Agents: A Case Study and Literature ReviewNeurosurgery 2017; 81(6): 899 doi: 10.1093/neuros/nyx072